Chabiotech Co Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Chabiotech Co Ltd with three other
miscellaneous service companies in Asia:
Hutchison China Meditech Limited
sales of 1.62 billion Chinese Renmimbi [US$237.22 million]
of which 69%
was Is Operating - Prescription Drugs PRC),
Takara Bio Inc
(29.38 billion Japanese Yen [US$261.73 million]
of which 90%
was Bio support), and
BGI Genomics Co Ltd
based in China
(2.10 billion Chinese Renmimbi [US$306.01 million]
of which 100%
was Genomics application industry).
Chabiotech Co Ltd reported sales of 418.88 billion Korean Won (US$374.48 million)
December of 2017.
decrease of 6.8%
versus 2016, when the company's sales were 449.26 billion Korean Won.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Chabiotech Co Ltd had sales
of 461.14 billion Korean Won.